Improved disease staging tool for hepatic encephalopathy, approved for use by FDA in phase 3 trials of IV ammonia scavenger (YAQ006) Dose-response data of oral ammonia scavenger (YAQ007) for ...

Higher patient-reported convenience and effectiveness of ALXN1840 compared to standard of care, including those who transitioned from standard of care to ALXN1840 in the extension portion of the Phase ...

THE LATE pop legend Linda Nolan’s beloved stepson Lloyd has died following his own battle with cancer. The tragedy comes just ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Roche launches innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity: Basel Wednesday, May 7, 2025, 10:00 Hrs [IST] Roche announced the launch ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

On a 5-point Likert scale, AI responses scored a 4.2 on both quality and empathy compared with scores of 3.0 on quality and 2 ...

Global research into the gut microbiome has exploded over the past decade, with most of the spotlight shining on the complex, ...

SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) ...

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a ...

Health officials in Los Angeles County have declared a community-wide outbreak of hepatitis A following a sharp rise in cases ...

Lacking awareness of metabolic dysfunction-associated steatohepatitis (MASH) constitutes a critical barrier for enhancing patient care, said Naim Alkhouri, MD. Awareness efforts can not only increase ...